Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix

Science
Loren D WalenskyStanley J Korsmeyer

Abstract

BCL-2 family proteins constitute a critical control point for the regulation of apoptosis. Protein interaction between BCL-2 members is a prominent mechanism of control and is mediated through the amphipathic alpha-helical BH3 segment, an essential death domain. We used a chemical strategy, termed hydrocarbon stapling, to generate BH3 peptides with improved pharmacologic properties. The stapled peptides, called "stabilized alpha-helix of BCL-2 domains" (SAHBs), proved to be helical, protease-resistant, and cell-permeable molecules that bound with increased affinity to multidomain BCL-2 member pockets. A SAHB of the BH3 domain from the BID protein specifically activated the apoptotic pathway to kill leukemia cells. In addition, SAHB effectively inhibited the growth of human leukemia xenografts in vivo. Hydrocarbon stapling of native peptides may provide a useful strategy for experimental and therapeutic modulation of protein-protein interactions in many signaling pathways.

References

Jun 21, 1985·Science·Y TsujimotoC M Croce
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·S FawellJ Barsoum
Nov 15, 1996·Genes & Development·K WangS J Korsmeyer
Nov 2, 2002·The Journal of Biological Chemistry·Jean Philippe RichardBernard Lebleu
Jun 5, 2003·The Journal of Biological Chemistry·Guillaume DrinJamal Temsamani
Sep 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Anne-Marie LeducArno F Spatola
Jan 28, 2004·Cell·Nika N Danial, Stanley J Korsmeyer
Mar 10, 2004·Bioorganic & Medicinal Chemistry Letters·Bin YangZiwei Huang

❮ Previous
Next ❯

Citations

Dec 23, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Susanne DymallaKarin Hoppe-Seyler
Mar 17, 2011·Amino Acids·Thomas A Edwards, Andrew J Wilson
Oct 31, 2007·Apoptosis : an International Journal on Programmed Cell Death·Karen S Yee, Karen H Vousden
Apr 25, 2007·Apoptosis : an International Journal on Programmed Cell Death·Brian LeberDavid W Andrews
Feb 12, 2009·Apoptosis : an International Journal on Programmed Cell Death·Vladimir GogvadzeBoris Zhivotovsky
Apr 20, 2006·Journal of Computer-aided Molecular Design·Ye CheGarland R Marshall
Sep 17, 2005·Journal of Bioenergetics and Biomembranes·Lucian Soane, Gary Fiskum
Apr 23, 2013·Journal of Clinical Monitoring and Computing·Elife Zerrin BagciMehmet C Camurdan
May 21, 2005·Pharmaceutical Research·Manabu Kinoshita, Kullervo Hynynen
Oct 17, 2006·Current Oncology Reports·Aaron D Schimmer
Oct 9, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C Avendaño, J C Menéndez
Oct 8, 2013·European Journal of Medicinal Chemistry·Zhichao ZhangHongkun Sheng
Jul 27, 2012·Expert Reviews in Molecular Medicine·Matthew C Smith, Jason E Gestwicki
Mar 21, 2008·Expert Reviews in Molecular Medicine·Alex W WhiteGhali Brahemi
Dec 28, 2007·Accounts of Chemical Research·Paul A WenderThomas H Pillow
Jul 27, 2011·Biochemistry·Arthur D Tinoco, Alan Saghatelian
Jun 11, 2011·Biomacromolecules·Amit Jain, Henry S Ashbaugh
Mar 7, 2012·Journal of Chemical Information and Modeling·Karim M ElSawyLeo S D Caves
Jul 13, 2006·Journal of the American Chemical Society·Deyun WangParamjit S Arora
Aug 18, 2010·Journal of the American Chemical Society·David L MasicaJeffrey J Gray
Dec 22, 2010·Journal of the American Chemical Society·Ji Hoon LeeHyun-Suk Lim
May 27, 2011·Journal of the American Chemical Society·Chris PhillipsStephen L Irving
Oct 8, 2011·Journal of the American Chemical Society·Agustina Rodriguez-GranilloVikas Nanda
Aug 19, 2011·Journal of the American Chemical Society·Brooke N BullockParamjit S Arora
Nov 2, 2011·Journal of the American Chemical Society·Melissa D BoersmaSamuel H Gellman
Dec 14, 2011·Journal of the American Chemical Society·Aaron M AlmeidaSamuel H Gellman
Dec 14, 2011·Journal of the American Chemical Society·Sohee BaekGrzegorz M Popowicz
May 3, 2012·Journal of the American Chemical Society·Holly S HaaseSamuel H Gellman
Aug 28, 2012·Journal of the American Chemical Society·Avinash MuppidiQing Lin
Sep 25, 2012·Journal of the American Chemical Society·Hyunil JoDoron C Greenbaum
Apr 9, 2013·Journal of the American Chemical Society·Alexander M SpokoynyBradley L Pentelute
Apr 2, 2009·Journal of the American Chemical Society·Peter S KutchukianEugene I Shakhnovich
Feb 18, 2010·Journal of the American Chemical Society·Arjel D BautistaAlanna Schepartz
Jun 14, 2013·Journal of Medicinal Chemistry·Ya-Qiu LongNouri Neamati
May 18, 2012·Molecular Pharmaceutics·Rebecca J BoohakerAnnette R Khaled
Sep 5, 2008·Molecular Pharmaceutics·Vaikunth CuchelkarJindrich Kopecek
Jun 19, 2009·Organic Letters·Omid Khakshoor, James S Nowick
Oct 25, 2008·Nature·Douglas R Green, Jerry E Chipuk
Jun 27, 2009·Cell Death and Differentiation·P E CzabotarD C S Huang
Aug 10, 2012·Leukemia·D R Pattabiraman, T J Gonda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

© 2021 Meta ULC. All rights reserved